Enhanced trans-cleavage activity using CRISPR-Cas12a variant designed to reduce steric inhibition by cis-cleavage products
Biosensors and Bioelectronics · 2025-01 · 267 · 116859
DOI: 10.1016/j.bios.2024.116859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-01. Verfasst von Injoo Hwang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cell Regeneration Research Center, Chonnam National University Hospital, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Biosensing Techniques, Hepatitis B virus, CRISPR-Associated Proteins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Korea Ministry of Science and ICT, The Catholic University of Korea.
Abstract (Originalsprache)
The CRISPR-Cas12a system has emerged as a promising tool for molecular diagnostics due to its indiscriminate trans-ssDNase activity. However, the sensitivity of Cas12a-based diagnostics remains insufficient for clinical use without a pre-amplification step such as loop-mediated isothermal amplification, and therefore the trans-cleavage activity of Cas12a needs to be enhanced. Here, we present a novel strategy to enhance the trans-cleavage activity of Cas12a by reducing the steric hindrance from cis-cleavage products. We have designed Cas12a variants with alanine mutations in the target strand loading (TSL) domain, resulting in reduced affinity for target strand (TS) overhangs to the catalytic site and significantly increased trans-cleavage efficiency by up to 5.8-fold. In addition, we used a novel salt dilution method to exploit the enhanced trans-cleavage activity of Cas12a under low ionic strength conditions (7-fold), significantly improving the sensitivity of our Cas12a-based detection system. To demonstrate the clinical potential of our Cas12a-based detection system, we validated its ability to detect small amounts of hepatitis B virus (HBV) DNA model using the combination of the KE1096AA Cas12a mutant and the salt dilution method, which enables the detection of DNA at atto-molar concentrations. Our strategy to enhance the trans-cleavage activity of Cas12a paves the way for the development of more sensitive and efficient Cas12a-based diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Regeneration Research Center, Chonnam National University Hospital, Gwangju, Republic of Korea.
- Department of Chemistry, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
- Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea; Department of Medical Sciences, Graduate School of the Catholic University of Korea, Seoul, 06…
Förderung
- Korea Ministry of Science and ICT
- The Catholic University of Korea
Zitieren
APA
Hwang, I., Song, Y. H., & Lee, S. (2025). Enhanced trans-cleavage activity using CRISPR-Cas12a variant designed to reduce steric inhibition by cis-cleavage products. Biosensors and Bioelectronics, 267, 116859. https://doi.org/10.1016/j.bios.2024.116859
Vancouver
Hwang I, Song YH, Lee S. Enhanced trans-cleavage activity using CRISPR-Cas12a variant designed to reduce steric inhibition by cis-cleavage products. Biosensors and Bioelectronics. 2025;267:116859. doi:10.1016/j.bios.2024.116859
BibTeX
@article{Hwang2025,
author = {Hwang, Injoo and Song, Yo Han and Lee, Sanghwa},
title = {Enhanced trans-cleavage activity using CRISPR-Cas12a variant designed to reduce steric inhibition by cis-cleavage products},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {267},
pages = {116859},
doi = {10.1016/j.bios.2024.116859}
}
EUVIMED